APA

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

Medifocus Inc. (Medifocus or the Company) (TSX VENTURE:MFS)(OTCQX:MDFZF)
announces that it has received final TSX Venture Exchange approval for its
previously announced private placement of 40,567,253 units (each a Unit) at a
price of $0.15 per Unit for gross proceeds of $6,085,088. Each Unit is comprised
of one common share (a Common Share) and one Series B Common Share purchase
warrant (a Warrant). Each Warrant entitles the holder to purchase one additional
Common Share at a price of $0.20 for a period of 24 months following the
completion of the offering. 18,367,253 of the Common Shares and Warrants issued
in connection with the private placement, and any Common Shares issued upon the
exercise of such Warrants, will have a hold period in Canada until October 9,
2012 and the remaining 22,200,000 Shares and Warrants issued in connection with
the private placement, and any Common Shares issued upon the exercise of such
Warrants, will have a hold period in Canada until October 22, 2012.


Further information about private placement can be found in the Company's June
8, 2012 and June 21, 2012 press releases. 


Medifocus owns a patented microwave focusing technology platform (the Adaptive
Phased Array ("APA") technology), which can precisely target and control
microwave energy to cause heating in cancerous tumors anywhere in the body
reliably and repeatedly. The ability to target tumors with a precision
controlled dose of heat can be used to destroy tumors at higher temperatures, to
treat tumors in combination with chemotherapy and/or radiation at moderate
temperatures for increased effectiveness and reduced toxicity and to trigger the
targeted release of therapeutic drugs and genes at tumor sites at lower
temperatures. While the core technology has been licensed from the Massachusetts
Institute of Technology, Medifocus has further refined the precision of the
microwave focusing and control ability and developed a commercial system
dedicated exclusively for the treatment of Breast Cancer. Please visit
www.medifocusinc.com for more details.

AlliancePharma Inc. (TSXV:APA)
Historical Stock Chart
From Jun 2024 to Jul 2024

AlliancePharma Inc. (TSXV:APA)
Historical Stock Chart
From Jul 2023 to Jul 2024